Mary Lou Clements‐Mann
Johns Hopkins University(US)
Publications by Year
Research Areas
Viral gastroenteritis research and epidemiology, Animal Virus Infections Studies, HIV Research and Treatment, Respiratory viral infections research, Immunotherapy and Immune Responses
Most-Cited Works
- → Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant(1997)414 cited
- → Evaluation of Two Live, Cold‐Passaged, Temperature‐Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children(1997)206 cited
- → Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1Mngp120, HIV‐1SF2Recombinant gp120, or Both Vaccines in Seronegative Adults(1998)190 cited
- → A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+Cytotoxic T Lymphocyte Responses in Seronegative Volunteers(1999)173 cited
- → Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group(1997)82 cited
- → Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults(2000)80 cited
- → Safety and immunogenicity of live attenuated human–bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants1This study was presented, in part, in a poster session at the Fifth Rotavirus Vaccine Workshop held on October 16–17, 1995, at the Centers for Disease Control and Prevention in Atlanta, GA. Informed consent was obtained from adult volunteers and the parents or guardians of pediatric participants. The guidelines for human experimentation of the U.S. Department of Health and Human Services and those of Johns Hopkins University and Vanderbilt University were followed in the conduct of these clinical studies.1(1999)77 cited
- → Safety and immunogenicity of live attenuated quadrivalent human–bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants(2001)68 cited
- → Immunogenicity of Two Doses of Yeast Recombinant Hepatitis B Vaccine in Healthy Older Adults(1997)26 cited
- → Clinical evaluation of a single oral dose of human‐bovine (UK) reassortant rotavirus vaccines Wa x UK (P1A[8],G6) and Wa x (DS‐1 x UK) (P1A[8],G2)(2002)20 cited